Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Gut

• Publication date

  2015-10-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1136/gutjnl-2015-310514PMID 26452628
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• BRAF-Targeted Therapy to Treat Superior Vena Cava Syndrome in a Patient With Metastatic Cancer.

  2015cited by this paper
• The future of immune checkpoint therapy

  2015cited by this paper
• Phase I/II safety and antitumor activity of nivolumab in patients with advanced hepatocellular carcinoma (HCC): CA209-040.

  2015cited by this paper
• CCL2 Shapes Macrophage Polarization by GM-CSF and M-CSF: Identification of CCL2/CCR2-Dependent Gene Expression Profile

  2014cited by this paper
• Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis

  2014cited by this paper
• Tumor-associated macrophages: from mechanisms to therapy.

  2014cited by this paper
• Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma.

  2013cited by this paper
• Anti‐tumour strategies aiming to target tumour‐associated macrophages

  2013cited by this paper
• Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?

  2013cited by this paper
• Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer

  2013cited by this paper
• Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation

  2013cited by this paper
• Monocytic CCR2(+) myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment.

  2012cited by this paper
• The Inflammatory Microenvironment in Hepatocellular Carcinoma: A Pivotal Role for Tumor-Associated Macrophages

  2012cited by this paper
• Origin and Functions of Tumor-Associated Myeloid Cells (TAMCs)

  2012cited by this paper
• Differential macrophage programming in the tumor microenvironment.

  2012cited by this paper
• Accessories to the crime: functions of cells recruited to the tumor microenvironment.

  2012cited by this paper
• Monocytic CCR2+ Myeloid Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD8 T Cell Infiltration Into the Tumor Microenvironment

  2011cited by this paper
• Transient mTOR Inhibition Facilitates Continuous Growth of Liver Tumors by Modulating the Maintenance of CD133+ Cell Populations

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• An essential role for monocyte chemoattractant protein‐1 in alcoholic liver injury: Regulation of proinflammatory cytokines and hepatic steatosis in mice

  2011cited by this paper
• Chemotaxis in cancer

  2011cited by this paper
• Therapeutic siRNA silencing in inflammatory monocytes

  2011cited by this paper
• CCL2 recruits inflammatory monocytes to facilitate breast tumor metastasis

  2011cited by this paper
• Monocyte recruitment during infection and inflammation

  2011cited by this paper
• Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury

  2011cited by this paper
• Hepatocellular carcinoma.

  2011cited by this paper
• Role of tumor-associated macrophages in the progression of hepatocellular carcinoma

  2011cited by this paper
• Functional role of chemokines in liver disease models

  2010cited by this paper
• Hepatocellular carcinoma: a global view

  2010cited by this paper
• Targeting chemokine (C-C motif) ligand 2 (CCL2) as an example of translation of cancer molecular biology to the clinic.

  2010cited by this paper
• Macrophages, innate immunity and cancer: balance, tolerance, and diversity.

  2010cited by this paper
• Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients.

  2010cited by this paper
• Development of Monocytes, Macrophages, and Dendritic Cells

  2010cited by this paper
• Macrophage diversity enhances tumor progression and metastasis.

  2010cited by this paper
• Fitness versus fatness: Moving beyond weight loss in nonalcoholic fatty liver disease

  2010cited by this paper
• Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth.

  2010cited by this paper
• High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection.

  2009cited by this paper
• Central Role of Tumor-Associated CD8+ T Effector/Memory Cells in Restoring Systemic Antitumor Immunity1

  2009cited by this paper
• Chemokine receptor antagonists: overcoming developmental hurdles

  2009cited by this paper
• Immunotherapy of HCC.

  2008cited by this paper
• Paradoxical roles of the immune system during cancer development

  2006cited by this paper
• Early and Late Recurrence After Liver Resection for Hepatocellular Carcinoma: Prognostic and Therapeutic Implications

  2006cited by this paper
• Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2

  2006cited by this paper
• Tumour-educated macrophages promote tumour progression and metastasis

  2004cited by this paper
• Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults

  2003cited by this paper
• Tumor-Associated Macrophage Infiltration in Pulmonary Adenocarcinoma: Association with Angiogenesis and Poor Prognosis

  1999cited by this paper
• Inhibition of macrophages with gadolinium chloride alters intercellular adhesion molecule‐1 expression in the liver during acute endotoxemia in rats

  1999cited by this paper
• Gadolinium induces macrophage apoptosis

  1996cited by this paper
• Hepatocellular carcinoma.

  1986cited by this paper
• Expression of liver phenotypes in cultured mouse hepatoma cells.

  1980cited by this paper
• Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment Prospects and Obstacles for Therapeutic Targeting of Function-enabling Stromal Cell Types

  year unknowncited by this paper

• Decoding mechanisms and therapeutic opportunities in testicular development diseases through macrophage immunology.

  2026cites this paper
• Rewiring tumor-associated macrophages in hepatocellular carcinoma

  2026cites this paper
• NSUN6 deficiency drives immune suppression in pancreatic cancer via the KDM5A-CCL2-macrophage axis

  2026cites this paper
• Paeoniflorin Alleviates Urushiol-Induced Pruritus in Mice by inhibiting Erk/CCL2 pathway.

  2026cites this paper
• The macrophage opera: from metabolic prolog to oncogenic crescendo in metabolic dysfunction-associated steatotic liver disease.

  2026cites this paper
• Beyond bacterial defences: the role of lysozyme in cancer

  2026cites this paper
• Chronic inflammation and immune response in hepatocellular carcinoma: a comprehensive literature review

  2026cites this paper
• Targeting the FBXW7-AKAP13-YAP axis suppresses gliomagenesis by dual inhibition of tumor invasion and macrophage recruitment.

  2026cites this paper
• Interactions and communications in hepatocellular carcinoma: Potential targets for chemo/radiosensitization.

  2026cites this paper
• HMGA2 promotes hepatocellular carcinoma progression by regulating tumor-associated macrophage via Notch1/CCL2 signaling.

  2026cites this paper
• The "Immune Rebellion" from the Intestines to the Liver: A Vicious Cycle That Causes the Liver to Collapse.

  2026cites this paper
• ZG16 represses tumor progression and M2 polarization of tumor-associated macrophages in hepatocellular carcinoma by promoting ubiquitination and degradation of SNX9 via binding to ITCH.

  2026cites this paper
• CCL11 promotes hepatocellular carcinoma recurrence after surgery by potentiating immunosuppressive CCR5 + CD206 + M2-like macrophages and promoting tumor invasiveness

  2026cites this paper
• Molecular mechanisms of tumor-associated macrophages in hepatocellular carcinoma development and therapy

  2026cites this paper
• Comprehensive genomic profiling of triple-negative breast cancer metastases identifies role of PKD1 in immunotherapy resistance.

  2026cites this paper
• Tumor‐Associated Macrophages as Therapeutic Targets: Deciphering Interaction Networks and Advancing Clinical Translation

  2026cites this paper
• Converting ‘cold’ to ‘hot’ hepatocellular carcinoma for improved immunotherapy (Review)

  2026cites this paper
• Modulating NOS2 of radiotherapy-recruited CCR2+ macrophages enhances radiosensitivity of hepatocellular carcinoma.

  2026cites this paper
• New insights into combined immunotherapy for hepatocellular carcinoma associated with liver cirrhosis

  2025cites this paper
• Cancer Reversion Therapy: Prospects, Progress and Future Directions

  2025cites this paper
• Complement C3 of tumor-derived extracellular vesicles promotes metastasis of RCC via recruitment of immunosuppressive myeloid cells

  2025cites this paper
• Targeting Microbe-Mediated Macrophage Education: A Novel Paradigm in Cancer Immunotherapy

  2025cites this paper
• Immune cell changes following chemotherapy in advanced pancreatic cancer with variations based on gender

  2025cites this paper
• Targeting the Dynamics Between TAMs and CAR‐T Cells in Solid Tumor Therapies

  2025cites this paper
• Cancer stem cells in hepatocellular carcinoma: therapy resistance and emerging treatments

  2025cites this paper
• PLAGL2 promotes HCC progression by recruiting tumour-associated macrophages via CCL2/CCR2 signalling.

  2025cites this paper
• Distinct Roles of Monocyte Subsets in Cancer

  2025cites this paper
• Cancer Manipulates Adjacent Adipose Tissue to Exploit Fatty Acids via HIF‐1α/CCL2/PPARα Axis: A Metabolic Circuit to Support Tumor Progression

  2025cites this paper
• Antagonism of estrogen-related receptor-α inhibits mitochondrial oxidative phosphorylation and reduces M2 macrophage infiltration in endometrial cancer

  2025cites this paper
• Macrophages in Lupus Nephritis: Insights into Its Pathogenesis and Emerging Treatments.

  2025cites this paper
• Molecular mechanisms of TAM-regulated tumorigenesis and progression in various types of radiotherapy and future prospects of radiation-immunotherapy combinations.

  2025cites this paper
• MCP-1-CCR2-M2 macrophages axis contributes to diffuse large B-cell lymphoma progression and inhibits antitumor immune response

  2025cites this paper
• The association between composite inflammatory indicators and the clinicopathological characteristics of differentiated thyroid carcinoma

  2025cites this paper
• A comprehensive bibliometric and visual analysis of tumor-associated macrophages in hepatocellular carcinoma

  2025cites this paper
• Pan-carcinoma data driven analysis reveals Platelet-Activating Factor Receptor (PTAFR) involvement in immunosuppressive tumor microenvironment signaling and clinical prognosis.

  2025cites this paper
• Identifying shared hub genes in LIRI and MASLD through bioinformatics analysis and machine learning

  2025cites this paper
• Orchestration of Tumor-Associated Macrophages in the Tumor Cell-Macrophage-CD8+ T Cell Loop for Cancer Immunotherapy

  2025cites this paper
• Screening Natural Cholesterol Analogs to Assemble Self‐Adjuvant Lipid Nanoparticles for Antigens Tagging Guided Therapeutic Tumor Vaccine

  2025cites this paper
• Uncovering the molecular signature of feline diffuse iris melanoma through transcriptomic analysis of disease severity

  2025cites this paper
• High-Risk PNPLA3 rs738409 Genotype Is Associated with Higher Concentrations of CCL2 in Liver Transplant Candidates with Alcoholic End-Stage Liver Disease

  2025cites this paper
• Pharmacological inhibition of the CCL2-CCR2 axis fails to reduce inflammation in a rat model of acute lung injury

  2025cites this paper
• Enhancing natural killer cell anti-tumour activity through macrophage manipulation

  2025cites this paper
• Construction of a prognostic model for hepatocellular carcinoma based on necrosis by sodium overload-related genes and identification of ANKRD13B as a new prognostic marker

  2025cites this paper
• Immunology, immunotherapy, and the tumor microenvironment in hepatocellular carcinoma: a comprehensive review

  2025cites this paper
• Microenvironmental regulation of solid tumour resistance to CAR T cell therapy

  2025influential citation
• A retrospective analysis exploring the association of pretreatment neutrophil-to-lymphocyte ratio and immune checkpoint inhibitor outcomes in patients with advanced NSCLC and liver metastases

  2025cites this paper
• Disruption of tumor-intrinsic PGAM5 increases anti-PD-1 efficacy through the CCL2 signaling pathway

  2025cites this paper
• Macrophage-targeted immunocytokine leverages myeloid, T, and NK cell synergy for cancer immunotherapy.

  2025cites this paper
• OTUD4-mediated inhibition of YAP1 signaling pathway in ovarian cancer: Implications for macrophage polarization and recruitment.

  2025cites this paper
• Spatial heterogeneity of the hepatocellular carcinoma microenvironment determines the efficacy of immunotherapy

  2025cites this paper
• Downregulation of CCR2 reduces ventricular remodeling after myocardial infarction by splenic nerve neuromodulation in acute and chronic rat models.

  2025cites this paper
• Integrated therapies for targeting the microenvironment of hepatocellular carcinoma.

  2025cites this paper
• Cancer-associated fibroblast-derived exosomes in cancer progression: a focus on hepatocellular carcinoma.

  2025cites this paper
• Macrophage Polarization in the Tumor Microenvironment of Hepatocellular Carcinoma: From Mechanistic Insights to Translational Therapies

  2025cites this paper
• Diagnostic, prognostic, and metastatic value of chemokines as biomarkers for oral squamous cell carcinoma and their precursor lesions - A systematic review.

  2025cites this paper
• Osteosarcoma cell–derived CCL2 facilitates lung metastasis via accumulation of tumor-associated macrophages

  2025cites this paper
• H3K36me3‐Guided m6A Modification of Oncogenic L1CAM‐AS1 Drives Macrophage Polarization and Immunotherapy Resistance in Hepatocellular Carcinoma

  2025cites this paper
• Characterizing macrophage diversity in colorectal malignancies through single-cell genomics

  2025cites this paper
• Therapeutic targeting of tumour-associated macrophage receptors

  2025cites this paper
• A comprehensive review on targeting diverse immune cells for anticancer therapy: beyond immune checkpoint inhibitors.

  2025cites this paper
• A Novel TLR4 Accessory Molecule Drives Hepatic Oncogenesis through Tumor-Associated Macrophages.

  2025cites this paper
• Tumor-infiltrating myeloid cells; mechanisms, functional significance, and targeting in cancer therapy

  2025cites this paper
• Identifying potential signatures of immune cells in hepatocellular carcinoma using integrative bioinformatics approaches and machine-learning strategies

  2025cites this paper
• Antitumor Research Based on Drug Delivery Carriers: Reversing the Polarization of Tumor-Associated Macrophages.

  2025cites this paper
• Harnessing nanoparticles for reshaping tumor immune microenvironment of hepatocellular carcinoma

  2025cites this paper
• CCL2/C–C chemokine receptor type 2‐mediated interactions among mast cells, basophils, and endothelial cells

  2025cites this paper
• Myeloid cells: key players in tumor microenvironments

  2025cites this paper
• The Role of Chemokine (C‐C Motif) Ligand 7 (CCL7) in Hepatocellular Carcinoma: Expression, Function, and Mechanisms

  2025cites this paper
• Gold nanoparticles modulate macrophage polarization to promote skeletal muscle regeneration

  2025cites this paper
• RAW264.7 Macrophages as a Polarization Model in the Context of Pancreatic Cancer and Chemokine Release

  2025cites this paper
• Exosomes Derived from Bone Marrow Mesenchymal Stem Cells Encapsulated in M2 Macrophage Cell Membrane Targeted to Inhibit Joint Periprosthetic Inflammation.

  2025cites this paper
• Stimulation of regulatory dendritic cells suppresses cytotoxic T cell function and alleviates DEN-induced liver injury, fibrosis and hepatocellular carcinoma

  2025cites this paper
• Cancer Stem Cells and Tumor-Associated Macrophages: Interactions and Therapeutic Opportunities.

  2025cites this paper
• Glutamate promotes CCL2 expression to recruit tumor-associated macrophages by restraining EZH2-mediated histone methylation in hepatocellular carcinoma

  2025cites this paper
• Immune Evasion in Cancer Metastasis: An Unappreciated Role of Monocytes

  2025cites this paper
• NLRP3 regulates macrophage function by M-CSF/M-CSFR signaling in acute radiation-induced lung injury.

  2025cites this paper
• Tumor-associated macrophages in radiotherapy: Mechanisms of polarization, immune regulation and therapeutic strategies.

  2025cites this paper
• Interactions in hepatic tumor microenvironment: Potential targets and modulations for effective therapy.

  2025cites this paper
• Tumor-associated macrophages in hepatocellular carcinoma: Cellular plasticity and therapy resistance in crosstalk

  2025cites this paper
• Multi-omics analysis identifies SNP-associated immune-related signatures by integrating Mendelian randomization and machine learning in hepatocellular carcinoma

  2025cites this paper
• Oncogenic CMTM6 drives M2a macrophages formation and fuels cervical cancer progression

  2025cites this paper
• PLAUR+ Neutrophils Drive Anti‐PD‐1 Therapy Resistance in Patients with Hepatocellular Carcinoma by Shaping an Immunosuppressive Microenvironment

  2025cites this paper
• Immune evasion from macrophages by NEAT1-induced CD24 in liver cancer

  2025cites this paper
• Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments

  2025cites this paper
• CKS2 Mediates Hepatocellular Carcinoma Recurrence After Hepatic Ischemia-Reperfusion Injury Related to M2 Macrophages

  2025cites this paper
• Progress in targeting tumor-associated macrophages in cancer immunotherapy

  2025cites this paper
• A Study on the Efficacy and Pharmacological Mechanism of Liposome Complexes Containing STING Agonist and Anti-PD-L1 Nanobody in Inhibiting HCC

  2025cites this paper
• Tumor-infiltrating lymphocytes and tumor-associated macrophages in cancer immunoediting: a targetable therapeutic axis

  2025cites this paper
• Immunotherapy resistance in MASLD-related hepatocellular carcinoma: special immune microenvironment and gut microbiota

  2025cites this paper
• Air pollution-related immune gene prognostic signature for hepatocellular carcinoma: network toxicology, machine learning and multi-omics analysis

  2025cites this paper
• Understanding the complexity of tumor-associated macrophages: Druggable and therapeutic insights

  2025cites this paper
• Macrophages: Traffic centers in the tumor immune microenvironment.

  2025cites this paper
• CCL2/CCR2 signaling pathway in tumorigenesis and metastasis (Review)

  2025cites this paper
• Anti-CD206 CAR T Cell Treatment Restores Fibrosis-Induced Loss of Dermal White Adipose Tissue

  2025cites this paper
• Harnessing Macrophages in Cancer Therapy: from Immune Modulators to Therapeutic Targets

  2025cites this paper
• Suppression of MCP-1, IFN-γ and IL-6 production of HNSCC ex vivo by pembrolizumab added to docetaxel and cisplatin (TP) exceeding those of TP alone is linked to improved survival

  2025cites this paper
• α7 nicotinic acetylcholine receptor agonist attenuates lipopolysaccharide-induced acute kidney injury in mice by reducing CCL2 expression in macrophages

  2025cites this paper
• hnRNPA2B1 Promotes Malignant Phenotype and Tumor Progression of Gastric Cancer Cells by Regulating Macrophage M2 Polarization

  2025cites this paper
• Chemokine (C-C Motif) Ligand 2/CCR2/Extracellular Signal-Regulated Kinase Signal Induced through Cancer Cell–Macrophage Interaction Contributes to Hepatocellular Carcinoma Progression

  2025cites this paper
• Targeting CXCR4-expressing TAMs in muscle-invasive bladder cancer to enhance tumor control after immunotherapy

  2025cites this paper